The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Nectar Lifesciences Ltd. Share Price
Pharmaceuticals & DrugsNectar Lifesciences Ltd. (INR)22.01-1 (-4.5%) 
Exchange ScripsBSE532649NSENECLIFEISININE023H01027
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Nectar Lifesciences Ltd. Performance
Market performance
Open price23.05
High23.24
Volumes1171792
Prev Close22.01
Low21.84
Closing date2025-06-18
Historical performance
1 Year High56.50
3 Year High56.50
5 Year High56.50
1 Year Low20.02
3 Year Low14.50
5 Year Low14.50
Nectar Lifesciences Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Nectar Lifesciences Ltd. Investment Returns
1 Year
-35.5%
3 Years
-2%
5 Years
-19.5%
10 Years
-31.3%
Nectar Lifesciences Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 23.16 | Bearish |
| 10-DMA | 23.54 | Bearish |
| 20-DMA | 24.49 | Bearish |
| 50-DMA | 23.44 | Bearish |
| 100-DMA | 26.47 | Bearish |
| 200-DMA | 32.85 | Bearish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 3 | 3 | 2 | 2 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 3 | 3 | 2 | 2 | 2 |
| Public Investors | 69238 | 69479 | 66738 | 58227 | 59943 |
| Government | 1 | 1 | 1 | 1 | 1 |
Nectar Lifesciences Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 243 | 531 | 113 | 114 |
| Operating Profit | 1759 | 1061 | 1699 | 1128 |
| Interest | 969 | 894 | 788 | 1120 |
| Depreciation | 607 | 591 | 570 | 603 |
| Profit Before Tax | 183 | -424 | 341 | -848 |
| Consolidated Net Profit | 50 | -242 | 250 | -733 |
| Adjusted EPS | --- | -1 | 1 | -3 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 224 | 224 | 224 | 224 |
| Total Reserves | 10468 | 10422 | 10655 | 10396 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | 1415 | 2131 | 2963 | 1264 |
| Total Liabilities | 21836 | 21686 | 23880 | 23758 |
| Capital Work in Progress | 658 | 778 | 851 | 986 |
| Total Assets | 21836 | 21686 | 23880 | 23758 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 2247 | 1337 | 950 | 214 |
| Cash Flow from Investing Activities | -170 | 517 | 166 | -286 |
| Cash Flow from Financing Activitie | -2054 | -1856 | -1194 | 115 |
| Net Cash Inflow / Outflow | 22 | -2 | -77 | 42 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 98.83.
- 3Y Stock Price CAGR of the stock is 1.7.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹1759 Million.
- The company generated revenue of ₹16841 Million in the previous financial year.
Nectar Lifesciences Ltd.
22.01-1 (-4.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 659970
No. of Shares: 29985.0
Performance:-34%
P/L: ₹-340030
Top Gainers
| Symbol | Change% |
|---|---|
| EMIL | 158.37(18%) |
| SILLYMONKS | 18(14%) |
| OPTIEMUS | 684.6(11%) |
| AAKASH | 9.7(11%) |
| PFOCUS | 130.98(10%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent